Table 1 Characteristics of antipsychotics in the FDA adverse event reporting system database

Atypical

96841

21151

21.8

2.5

(2.4-2.5)

Aripiprazole

17093

4045

23.7

2.6

(2.5-2.7)

Clozapine

18217

2614

14.3

1.4

(1.3-1.5)

Olanzapine

22200

8423

37.9

5.3

(5.1-5.4)

Quetiapine

43169

12471

28.9

3.5

(3.4-3.6)

Perospirone

83

26

31.3

3.8

(2.4-6.1)

Risperidone

22121

5968

27.0

3.1

(3.0-3.2)

Zotepine

134

31

23.1

2.5

(1.7-3.8)

Typical

19569

3948

20.2

2.1

(2.1-2.2)

Bromperidol

48

11

22.9

2.5

(1.3-4.9)

Chlorpromazine

2812

1003

35.7

4.6

(4.3-5.0)

Fluphenazine

923

234

25.4

2.8

(2.4-3.3)

Haloperidol

10922

3445

31.5

3.9

(3.7-4.0)

Levomepromazine

799

166

20.8

2.2

(1.8-2.6)

Moperone

0

0

-

-

Nemonapride

4

1

25.0

2.8

(0.3-26.8)

Perphenazine

911

341

37.4

5.0

(4.4-5.7)

Pimozide

246

65

26.4

3.0

(2.3-4.0)

Pipamperone

207

26

12.6

1.2

(0.8-1.8)

Prochlorperazine

9103

1800

19.8

2.1

(2.0-2.2)

Propericiazine

190

45

23.7

2.6

(1.9-3.6)

Spiperone

1

0

-

-

Sulpiride

1809

331

18.3

1.9

(1.7-2.1)

Sultopride

97

11

11.3

1.1

(0.6-2.0)

Thioridazine

574

160

27.9

3.2

(2.7-3.9)

Tiapride

336

81

24.1

2.7

(2.1-3.4)

Timiperone

15

4

26.7

3.0

(1.0-9.5)

Trifluoperazine

619

274

44.3

6.6

(5.7-7.8)